The executive reduced holdings by 18,869 shares following earnings-driven gains, retaining $30.4 million in equity.
Encompass Health Corporation’s CFO Douglas Coltharp sold 18,869 shares on August 10 for $2.4 million, executed at an average price of $125.38. The transaction followed a post-earnings share rally, closing at $125.81 the same day.
The company, with a $12.5 billion market capitalization, reported trailing twelve-month revenue of $6.2 billion and net income of $621.0 million. Coltharp’s sale represents a minor reduction in his total equity exposure, which remains substantial through trusts and family holdings.
After the sale, Coltharp retains 241,000 shares, valued at approximately $30.4 million, or 0.2% of outstanding shares. The disposal does not signal a broader divestment strategy, as most holdings remain indirectly held.